Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections

被引:77
|
作者
Blairon, L
Wittebole, X
Laterre, PF
机构
[1] St Luc Univ Hosp, Dept Biol Clin, Brussels, Belgium
[2] St Luc Univ Hosp, Dept Intens Care & Emergency Med, Brussels, Belgium
来源
JOURNAL OF INFECTIOUS DISEASES | 2003年 / 187卷 / 02期
关键词
D O I
10.1086/346046
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopolysaccharide-binding protein (LBP) is increased in patients with severe gram-negative infections, but LBP serum levels have not been reported for in patients with gram-positive and fungal infections. LBP serum levels were determined in patients with severe sepsis secondary to gram-positive or fungal infections and were compared with LBP serum levels obtained from patients with gram-negative mixed infections and from healthy volunteers. Thirty-seven episodes of severe sepsis were analyzed among 24 patients. LBP serum levels were significantly increased in patients with severe sepsis (46.4 +/- 28.3 mug/mL), compared with that of healthy volunteers (5.7 +/- 1.9 mug/mL; P < .0001). On the other hand, LBP serum levels obtained from patients with gram-negative infections (40.80 +/- 34.79 μg/mL) did not differ from those obtained from patients with gram-positive (35.55 +/- 23.95 μg/mL) or fungal (39.90 +/- 22.19 μg/mL) infections. These data suggest that LBP is an aspecific marker of sepsis, and the response was not clearly correlated with severity. Furthermore, in patients with multiple episodes of sepsis, LBP response seems to be of lesser magnitude after each subsequent episode of severe sepsis.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 50 条
  • [41] Overweight and obese poorly controlled severe asthma patients have increased levels of gut permeability biomarkers lipopolysaccharide-binding protein (LBP) and calprotectin
    Parenti, C.
    Murphy, A. M.
    Lad, N.
    McTernan, P. G.
    Nelson, C. P.
    Sharpe, G. R.
    Barber, C.
    Abadalkareem, R.
    Azim, A.
    Kurukulaaratchy, R. J.
    Haitchi, H. M.
    Williams, N. C.
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2022, 81 (OCE4)
  • [42] TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis
    Mewes, Caspar
    Alexander, Tessa
    Buettner, Benedikt
    Hinz, Jose
    Alpert, Ayelet
    Popov, Aron-F
    Ghadimi, Michael
    Beissbarth, Tim
    Tzvetkov, Mladen
    Grade, Marian
    Quintel, Michael
    Bergmann, Ingo
    Mansur, Ashham
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 16
  • [43] TROUGH SERUM VANCOMYCIN LEVELS PREDICT THE RELAPSE OF GRAM-POSITIVE PERITONITIS IN PERITONEAL-DIALYSIS PATIENTS
    MULHERN, JG
    BRADEN, GL
    OSHEA, MH
    MADDEN, RL
    LIPKOWITZ, GS
    GERMAIN, MJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (04) : 611 - 615
  • [44] The diagnostic ability of procalcitonin to differentiate Gram-negative bacteria from Gram-positive bacteria and fungal bloodstream infections in critically ill patients
    Wang, Di
    Tao, Xiaogen
    Guo, Wei
    Liu, Haihua
    Cheng, Shaohui
    Wang, Jinquan
    [J]. EUROPEAN JOURNAL OF INFLAMMATION, 2019, 17 : 1 - 6
  • [45] Population Pharmacokinetics and Pharmacodynamics of Teicoplanin and C-Reactive Protein in Hospitalized Patients With Gram-Positive Infections
    Ogami, Chika
    Tsuji, Yasuhiro
    Muraki, Yuichi
    Mizoguchi, Akiko
    Okuda, Masahiro
    To, Hideto
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (02): : 175 - 188
  • [46] SERUM LIPOPOLYSACCHARIDE-BINDING PROTEIN AS A MARKER OF BACTERIAL TRANSLOCATION AND INCREASED LONG-TERM MORTALITY IN CIRRHOTIC PATIENTS
    Zharkova, M. S.
    Maevskaya, M. V.
    Ivashkin, V. T.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S238 - S238
  • [47] Changes in acute-phase proteins levels and neutrophil lipopolysaccharide-binding activity in peripheral blood in patients with acute intestinal infections
    Malov, VA
    Grachev, SV
    Nekhaev, SG
    Likhoded, VG
    Brodov, LE
    [J]. TERAPEVTICHESKII ARKHIV, 1996, 68 (11): : 23 - 27
  • [48] Serum Lipopolysaccharide-binding Protein and Soluble CD14 Are Markers of Disease Activity in Patients with Crohn's Disease
    Lakatos, Peter Laszlo
    Kiss, Lajos Sandor
    Palatka, Karoly
    Altorjay, Istvan
    Antal-Szalmas, Peter
    Palyu, Eszter
    Udvardy, Miklos
    Molnar, Tamas
    Farkas, Klaudia
    Veres, Gabor
    Harsfalvi, Jolan
    Papp, Janos
    Papp, Maria
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (03) : 767 - 777
  • [49] Identification of the Zinc Finger Protein ZRANB2 as a Novel Maternal Lipopolysaccharide-binding Protein That Protects Embryos of Zebrafish against Gram-negative Bacterial Infections
    Wang, Xia
    Du, Xiaoyuan
    Li, Hongyan
    Zhang, Shicui
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (08) : 4019 - 4034
  • [50] Serum concentrations of lipopolysaccharide-binding protein as a biochemical marker to differentiate microbial etiology in patients with community-acquired pneumonia
    Masiá, M
    Gutiérrez, F
    Llorca, B
    Navarro, JC
    Mirete, C
    Padilla, S
    Hernández, I
    Flores, N
    [J]. CLINICAL CHEMISTRY, 2004, 50 (09) : 1661 - 1664